drugset / Trial / NCT01776047

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

NCT01776047

Phase 1 Completed 51 enrolled Dong-A Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I

Timeline

Start
2012-07
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject G-0081 Unknown 160 mg
Comparator Valsartan Small molecule 160 mg

Indications

No indication recorded.